References
- ACOG steps up efforts to get emergency contraception to women. May 8, 2006. The
American College of Obstetricians and Gynecologists. http://www.acog.org/from_home/publications/press_releases/
nr05-08-06-1.cfm. Accessed February 25, 2008.
- Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions
in 2000-2001. Perspect Sex Reprod Health. 2002;34:294-303.
- Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled
trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives
for emergency contraception. Lancet. 1998;352:428-433.
- Food and Drug Administration. Center for Drug Evaluation and Research Application
Number: NDA21045. www.fda.gov/cder/foi/nda/99/21-045_Plan%20B_medr.pdf. Accessed
March 10, 2008.
- Kavanaugh ML, Schwarz EB. Counseling about the use of emergency contraception in
the United States. Perspect Sex Reprod Health. 2008;40(2):81-86.
- The Emergency Contraception Website. Types of emergency contraception. Emergency
contraceptive pills worldwide. http://ec.princeton.edu/questions/dedicated.html.
Accessed February 25, 2008.
- Hamoda H, Ashok PW, Stalder C, Flett GMM, Kennedy E, Templeton A. A randomized trial
of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet Gynecol.
2004;104(6):1307-1313.
- von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens
of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
Lancet. 2002;360(9348):1803-1810.
- Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness
and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.
Contraception. 2002;66(4):269-273.
- Emergency contraception. November 2005. The Henry J. Kaiser Family Foundation: Womens
Health Policy. http://www.kff.org/womenshealth/3344-03.cfm.
Accessed February 25, 2008.
- Emergency contraceptive pills. February 2004. The Henry J. Kaiser Family Foundation:
Womens Health Policy. http://www.kff.org/womenshealth/3344-02.cfm.
Accessed February 25, 2008.
View Important Safety Information and
Prescribing Information.
Important Safety Information
Next Choice® is not effective if you’re already pregnant, and it will
not terminate an existing pregnancy. Next Choice does not protect against
HIV and other sexually transmitted diseases (STDs). Side effects may include nausea,
abdominal pain, fatigue, headache, changes in your period, dizziness, and breast
tenderness. If your period is more than a week late, you may be pregnant. If you
have severe abdominal pain, you may have an ectopic pregnancy, and you should get
immediate medical help.
To report side effects of prescription drugs to the FDA, visit
fda.gov/medwatch or call 1-800-FDA-1088.
For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.
This Web site is intended for United States Prescribers, Pharmacists & Consumers.